Early Detection of Alzheimer’s through Retinal Scan

06:24 EDT 18 Aug 2017 | Genetic Engineering News

The burden of Alzheimer’s disease (AD) goes far beyond the afflicted patient, affecting family, friends, and a significant portion of the healthcare system. Currently, there are more than 5 million individuals living with AD in the U.S., incurring $259 billion in healthcare costs. With costs estimated to rise to $1.1 trillion by 2050 as the number of AD cases could surpass 16 million, it is imperative that diagnostic tests be developed to detect early warning signs that signal the onset of the disease—at the very least to allow patients and their family time to prepare for various eventualities.         Now, a team of neuroscientists at Cedars-Sinai have developed a noninvasive eye scan that could potentially detect the key signs of AD years before patients experience symptoms. Findings from the study—published recently in JCI Insight in an article entitled “ Retinal Amyloid Pathology and Proof-of-Concept Imaging Trial in Alzheimer’s ...

Original Article: Early Detection of Alzheimer’s through Retinal Scan


More From BioPortfolio on "Early Detection of Alzheimer’s through Retinal Scan"

Quick Search


Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...